Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
Clinical trial NCT03786770 · COMPLETED
Trial details
- NCT number
- NCT03786770
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2020-03-09
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.